Systemic PBM therapy as a new treatment tool

In movies or dramas, there are often scenes in which a person who shakes his hands exceptionally much is diagnosed with Parkinson's disease. The disease is neurodegenerative, first discovered by British physician James Parkinson at the end of the 19th century. It is speculated that this disease occurs when dopamine is not secreted properly or is lost in our brain. It is not a rare disease because it occurs in one in 1,000 people, and it is characterized by a population that occurs mainly in old age.

When Parkinson's disease occurs, there are many tremors. Most commonly, hand tremors occur, and in addition, various symptoms such as dysphagia, constipation, hyperhidrosis, and autonomic nervous breakdown are often present. Also, the movement slows down and the range of movement decreases.

For example, your steps may be smaller, or it may take much longer to cover the same 1 meter. It also affects muscle movement, so there is less movement of the face, and the mouth often opens and drools.
Because there's no way to go back to the past yet, guardians of patients with this disease often used to say that there's no future, there's no hope.
Now, however, the Parkinson's disease is coming to an end and hope is beginning to show.

It's because of "Photobiomodulation" and "hydrogen inhalation therapy."

A U.S. university researcher already found that PBM therapy had a beneficial effect on Parkinson's disease in 2008, and various studies have since shown that PBM (photomotomodulation) therapy reduces symptoms of alpha synuclein, one of the symptoms of Parkinson's disease.

Alpha synuclein is a protein that helps neurotransmission between brain cells. Since this substance is the main cause of Parkinson's disease, reducing it means reducing or eliminating the cause of Parkinson's disease. Of course, this is not the only cause of Parkinson's disease.

Secondary Parkinson's disease can be caused by stroke, carbon monoxide poisoning, or trauma such as Japanese encephalitis, drug addiction, or traffic accidents. In addition, trauma is not only caused by car accidents, but also by repeated heavy impacts, such as the heading movements of boxing or football, so athletes often suffer from Parkinson's disease. Repeated strokes are also a major cause of Parkinson's disease.

In the case of alpha synuclein mentioned above, abnormal protein accumulates in nerve cells, neurons necrosis and Parkinson's disease develops, and this alpha synuclein first begins to accumulate in the brain stem, which connects the brain and our body, and then gradually accumulates until it reaches the substantia nigra of the midbrain skin.

And when as little as 50 percent or as many as 70 percent of the brain cells in the substantia nigra are destroyed, symptoms such as hand tremors and bradykinesia that we often observe appear.

The substantia nigra is an organ that produces dopamine, as this substantia nigra is damaged, dopamine is not secreted properly, leading to Parkinson's disease, and over time, alpha-synuclein spreads to all areas of the brain, leading not only to Parkinson's disease but also to dementia. That's why it's important to remove and reduce alpha-synuclein. 

Typically, when dopamine production drops below 70 percent, people experience motor symptoms caused by Parkinson's disease, such as difficulty with chopsticks and penmanship, so they often use a spoon or seek help from others when eating. It's hard to do one-handed movements, so sometimes you use both hands. Neurodegeneration caused by alpha-synuclein continues to worsen over time.

At first, only one hand trembles and the other hand is holding the movement, but over time, both hands tremble and motor skills decrease, making it difficult to move or symptoms of ataxia such as falling while walking.

Systemic PBM (Photobiomodulation) therapy has been shown to be effective in removing or reducing such alpha-synuclein. In 2016, experiments on monkeys with Parkinson's disease showed that near-infrared light was effective in neuroprotection, and the majority of monkeys showed improvement when MPTP injections were given a week after implanting a visible red light (670 nm) optical fiber device in the brain.

Systemic PBM therapy uses a relatively low power density and uses red or near-infrared rays transmitted by lasers or LEDs to stimulate the brain to prevent neurons from degeneration. The reason is that all nerve cells are connected, and in the past, topical PBM therapy or electrical brain stimulation was performed for patients suffering from Parkinson's disease, but in the United States, systemic PBM therapy is said to have a significant effect by controlling the whole body.

Systemic BPM therapy has already been conducted in clinical trials on many Parkinson's patients and has already yielded significant results, and above all, it is a non-pharmacological treatment that does not worry about side effects, so it is a treatment that is spreading a lot by word of mouth among patients and caregivers.

In addition, molecular hydrogen inhalation therapy can be used in combination with systemic PBM therapy as a way to achieve a synergistic effect. Hydrogen inhaled through the respiratory tract enters the blood, tissue cells, bones, brain, and eyes directly, so it can be quickly distributed into the body without waste. Through this, hydrogen is supplied to the brain, which is the core of Parkinson's disease, which can reduce neuronal disorders and inhibit free radicals to help relieve and prevent symptoms.

In addition, hydrogen inhalation therapy is known to have a significant effect not only on Parkinson's disease but also on strokes such as cerebral hemorrhage and cerebral infarction, and in this case, it can not only prevent cerebrovascular disease but also suppress damage to the cranial nerves that may occur after stroke, thereby reducing neuronal disorders and alleviating the onset and symptoms of Parkinson's disease.

Much of Parkinson's disease remains uncharted territory, and while there is a long way to go for a complete cure, little by little there is hope. If you are struggling with Parkinson's disease or are struggling with it, you may want to learn about systemic PBM therapy or hydrogen inhalation.

 

Hue Light’s whole-body PBM Chamber